Ami Organics IPO subscribed 5x, Vijaya Diagnostic 0.5x on Day-2

Ami is a pharma-focused specialty chemicals firm; Vijaya Diagnostic is among the largest diagnostic chains in southern India

START-UPS, investors, markets, IPO, companies, funds
Illustration: Binay Sinha
BS Reporter New Delhi
1 min read Last Updated : Sep 02 2021 | 11:33 PM IST
Ami Organics’ initial public offering (IPO) was subscribed nearly 5 times, while that of Vijaya Diagnostic was half covered on Thursday. Both IPOs close on Friday. Ami is a specialty chemicals firm focused on the pharma industry. Its IPO comprises Rs 200-crore fresh fund raise and Rs 370-crore secondary share sale. The price band for its IPO is Rs 603-610 per share. At the top-end the company will have a market cap of Rs 2,223 crore and is valued at 41.2 times its FY21 earnings. Vijaya Diagnostic is among the largest diagnostic chains in southern India. Its IPO is entirely a secondary share sale worth Rs 1,894 crore. Vijaya’s price band is Rs 522 to 531 per share. At the top-end, the company will have a market cap of Rs 5,414 crore and will be valued at 63.8 times its FY21 earnings.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :IPOIPOs

Next Story